Cann Group Ltd (ASX: CAN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cann Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$9.53 million
P/E Ratio
0.52
Dividend Yield
0.00%
Shares Outstanding
1.59 billion
Earnings per share
0.012
Dividend per share
N/A
Year To Date Return
-44.44%
Earnings Yield
191.67%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cann Group Ltd (ASX: CAN)
Latest News
Cannabis Shares
Buying ASX cannabis stocks? Here's what the Victorian government is considering right now
Cannabis Shares
Looking to buy ASX cannabis shares right now? You'll want to watch this
Share Fallers
Why Ampol, Cann, Reliance Worldwide, and South32 shares are dropping
Cannabis Shares
Why is everyone talking about ASX cannabis shares all of a sudden?
Cannabis Shares
Why are these 2 ASX cannabis shares booming all of a sudden?
Cannabis Shares
Can ASX cannabis shares ever fully recover?
Share Gainers
Why Argosy Minerals, Cann, OZ Minerals, and PointsBet shares are pushing higher
Cannabis Shares
Why is the Cann share price smoking out the ASX by 20% today
Cannabis Shares
Remember when ASX cannabis shares were smoking hot? Where are they now?
Cannabis Shares
ASX cannabis shares in spotlight amid COVID prevention research
Share Gainers
Beaten up ASX cannabis shares showing signs of life
Cannabis Shares
ASX cannabis shares eyeing $63 billion in legal global sales
CAN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cann Group Ltd
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
CAN Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 25 Mar 2026 | $0.01 | $0.00 | 0.00% | 5,062,641 | $0.01 | $0.01 | $0.01 |
| 24 Mar 2026 | $0.01 | $0.00 | 0.00% | 1,431,470 | $0.01 | $0.01 | $0.01 |
| 23 Mar 2026 | $0.01 | $0.00 | 0.00% | 2,424,492 | $0.01 | $0.01 | $0.01 |
| 20 Mar 2026 | $0.01 | $0.00 | 0.00% | 1,360,528 | $0.01 | $0.01 | $0.01 |
| 19 Mar 2026 | $0.01 | $0.00 | 0.00% | 15,008,446 | $0.01 | $0.01 | $0.01 |
| 18 Mar 2026 | $0.01 | $0.00 | 0.00% | 1,091,154 | $0.01 | $0.01 | $0.01 |
| 17 Mar 2026 | $0.01 | $0.00 | 0.00% | 560,148 | $0.01 | $0.01 | $0.01 |
| 16 Mar 2026 | $0.01 | $0.00 | 0.00% | 3,471,598 | $0.01 | $0.01 | $0.01 |
| 13 Mar 2026 | $0.01 | $0.00 | 0.00% | 619,373 | $0.01 | $0.01 | $0.01 |
| 12 Mar 2026 | $0.01 | $0.00 | 0.00% | 182,098 | $0.01 | $0.01 | $0.01 |
| 11 Mar 2026 | $0.01 | $0.00 | 0.00% | 705,515 | $0.01 | $0.01 | $0.01 |
| 10 Mar 2026 | $0.01 | $0.00 | 0.00% | 1,664,165 | $0.01 | $0.01 | $0.01 |
| 09 Mar 2026 | $0.01 | $0.00 | 0.00% | 496,369 | $0.01 | $0.01 | $0.01 |
| 06 Mar 2026 | $0.01 | $0.00 | 0.00% | 1,615,442 | $0.01 | $0.01 | $0.01 |
| 05 Mar 2026 | $0.01 | $0.00 | 0.00% | 253,101 | $0.01 | $0.01 | $0.01 |
| 04 Mar 2026 | $0.01 | $0.00 | 0.00% | 150,774 | $0.01 | $0.01 | $0.01 |
| 03 Mar 2026 | $0.01 | $0.00 | 0.00% | 521,256 | $0.01 | $0.01 | $0.01 |
| 02 Mar 2026 | $0.01 | $0.00 | 0.00% | 13,550,578 | $0.01 | $0.01 | $0.01 |
| 27 Feb 2026 | $0.01 | $0.00 | 0.00% | 5,057,597 | $0.01 | $0.01 | $0.01 |
| 26 Feb 2026 | $0.01 | $0.00 | 0.00% | 215,101 | $0.01 | $0.01 | $0.01 |
| 25 Feb 2026 | $0.01 | $0.00 | 0.00% | 4,203,165 | $0.01 | $0.01 | $0.01 |
| 24 Feb 2026 | $0.01 | $0.00 | 0.00% | 2,866,787 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 24 Dec 2025 | Mike Ryan | Issued | 2,608,696 | $23,478 |
Placement.
|
| 24 Dec 2025 | Jennifer (Jenni) Pilcher | Issued | 4,347,826 | $39,130 |
Placement.
|
| 10 Dec 2025 | Jennifer (Jenni) Pilcher | Issued | 9,000,000 | $72,000 |
Issue of options.
|
| 10 Dec 2025 | Peter Kopanidis | Issued | 600,000 | $4,800 |
Issue of securities.
|
| 10 Dec 2025 | Douglas (Doug) Rathbone | Issued | 600,000 | $4,800 |
Issue of securities.
|
| 04 Dec 2025 | Jennifer (Jenni) Pilcher | Issued | 4,347,826 | $50,000 |
Placement.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Douglas (Doug) John Rathbone | Non-Executive Director | Mar 2015 |
Mr Rathbone is an experienced public company director. He is Chairman of the Rathbone Wine Group, Director of Cotton Seed Distributors, Go Resources and AgBiTech. He is also a Chairman of Health Food Holdings and Delta Agribusiness Pty Ltd. Doug is an Honorary Life Governor of the Royal Children's Hospital. He is President of My Room Children's Cancer Charity Limited and founder of Children's Cancer Foundation. Doug brings to the Board experienced management and corporate governance skills together with a passion to grow the business. He is member of Risk Committee.
|
| Ms Jennifer (Jenni) Pilcher | Chief Executive OfficerManaging Director | Sep 2020 |
Ms Pilcher has years of senior executive experience for ASX-listed companies in the medical and biotechnology sectors. She has also held senior finance roles at ASX200 company Spotless Group, Cadbury Schweppes plc, and international pharmaceutical group Medeva plc., based in London, UK.
|
| Mr Peter Kopanidis | Non-Executive Director | Mar 2025 |
Mr Kopanidis has over 30 years of experience as a finance professional in a range of industries, including manufacturing, telecommunications, healthcare, insurance, financial services and FMCG. Most recently, Peter has held senior executive roles leading investor relations, corporate treasury, and corporate finance at Medibank, Telstra, Treasury Wine Estates and Foster's Group. He is a Director and owner of Petra Investor Relations & Debt Advisory Pty Ltd, a service provider to ASX-listed companies. Peter started his career as an Auditor at KPMG. He is chair of Risk Committee.
|
| Mr Mike Ryan | Non-Executive ChairmanNon-Executive Director | Dec 2025 |
--
|
| Mr Steven Notaro | Company Secretary | May 2024 |
-
|
| Steven Notaro | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Adsd Soodin Holdings Pty Ltd | 17,721,490 | 2.67% |
| Eighteen Holdings Pty Ltd | 15,098,561 | 2.28% |
| Mr Philip Jacobsen & Mrs Maxine Jacobsen | 13,892,674 | 2.09% |
| Ryan Prue Pty Ltd | 13,614,888 | 2.05% |
| Citicorp Nominees Pty Limited | 8,008,436 | 1.21% |
| Mr Ryan Prue | 7,125,000 | 1.07% |
| T R Samuels Transport Pty Limited | 7,043,306 | 1.06% |
| Mullacam Pty Ltd | 6,779,975 | 1.02% |
| Mr Xuelong Sun | 6,777,414 | 1.02% |
| Mr Jiashun Yang | 6,530,000 | 0.98% |
| Mr Ryan Prue i | 6,050,000 | 0.91% |
| Flag Capital Pty Ltd | 5,876,453 | 0.89% |
| Mrs Rosita Xin Ang | 5,500,000 | 0.83% |
| Mr Ivor William Van Der Sluys | 5,250,000 | 0.79% |
| Ryan Prue Pty Ltd i | 4,835,112 | 0.73% |
| Mr Christopher John Page | 4,750,000 | 0.72% |
| Supernova Fund Pty Ltd | 4,341,363 | 0.65% |
| Invia Custodian Pty Limited | 4,100,000 | 0.62% |
| Mr Jarrod Paul Amiguet | 3,860,696 | 0.58% |
| Obsidian Global Gp Llc | 3,849,000 | 0.58% |